Risk factors for extreme-drug resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies

American Journal of Infection Control

Volumn 41, Issue 2, 2013, Pages 140-144

  Liew, Yin Xin ^a   Tan, Thuan Tong ^a   Lee, Winnie ^a   Ng, Jern Lin ^a   Chia, De Qing ^a   Wong, Gee Chuan ^a   Kwa, Andrea L ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Gram negative resistant infection; Leukemia; Matched case control study

Indexed keywords

AMIKACIN; AMOXICILLIN; AZTREONAM; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOXACILLIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; POLYMYXIN B; STREPTOMYCIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BONE MARROW BIOPSY; CANCER PATIENT; CASE CONTROL STUDY; CONTROLLED STUDY; EXTREME DRUG RESISTANT PSEUDOMONAS AERUGINOSA INFECTION; FEBRILE NEUTROPENIA; FEMALE; FOLEY BALLOON CATHETER; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN TISSUE; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PSEUDOMONAS INFECTION; PSEUDOMONAS PNEUMONIA; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; SEPSIS; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84873076485     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2012.02.025     Document Type: Article

References (22)

1. V. Aloush, S. Navon-Venezia, Y. Seigman-Igra, S. Cabili, and Y. Carmeli Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact Antimicrob Agents Chemother 50 2006 43 48
2. M.E. Falagas, and I.A. Bliziotis Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents 29 2007 630 636
3. B. Cao, H. Wang, H. Sun, Y. Zhu, and M. Chen Risk factors and clinical outcomes of nosocomial multidrug-resistant Pseudomonas aeruginosa infections J Hosp Infect 57 2004 112 118
4. R.E. Siegel Emerging gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences Respir Care 53 2008 471 479
5. E. Paramythiotou, J.C. Lucet, J.F. Timsit, D. Vanjak, C. Paugam-Burtz, and J.L. Trouillet Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity Clin Infect Dis 38 2004 670 677
6. A.D. Harris, D. Smith, J.A. Johnson, D.D. Bradham, and M.C. Roghmann Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients Clin Infect Dis 34 2002 340 345
7. E.B. El Amari, E. Chamot, R. Auckenthaler, J.C. Pechere, and C. Van Delden Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates Clin Infect Dis 33 2001 1859 1864
8. A.P. Zavascki, A.L. Barth, J.F. Fernandes, A.L. Moro, A.L. Goncalves, and L.Z. Goldani Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-β-lactamase-mediated multidrug resistance: a prospective observational study Crit Care 10 2006 R114
9. T.C. Horan, M. Andrus, and M.A. Dudeck CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting Am J Infect Control 36 2008 309 332
10. S.N. O'Brien, N.M. Blijlevens, T.H. Mahfouz, and E.J. Anaissie Infections in patients with hematological cancer: recent developments Hematology Am Soc Hematol Educ Program 2003 438 472
11. D.L. Paterson, and Y. Doi A step closer to extreme drug resistance (XDR) in gram-negative bacilli Clin Infect Dis 45 2007 1179 1181
12. A.D. Harris, M.H. Samore, M. Lipsitch, K.S. Kaye, E. Perencevich, and Y. Carmeli Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli Clin Infect Dis 2002 34 2002 1558 1563
13. E.M. D'Agata Methodologic issues of case-control studies: a review of established and newly recognized limitations Infect Control Hosp Epidemiol 26 2005 338 341
14. D. Talon, G. Capellier, A. Boillot, and Y. Michel-Briand Use of pulsed-field gel electrophoresis as an epidemiologic tool during an outbreak of Pseudomonas aeruginosa lung infections in an intensive care unit Intensive Care Med 21 1995 996 1002
15. TT Tan TK, ML Ling, BH Tan. Molecular epidemiology and characterization of extensive drug-resistant Pseudomonas aeruginosa outbreak in a hematology unit. Presented at the 20th European Congress of Clinical Microbiology and Infectious Diseases. Vienna, Austria, April 10-13, 2010.
16. D.D. Benoit, P.O. Depuydt, R.A. Peleman, F.C. Offner, and K.H. Vandewoude Documented and clinically suspected bacterial infection precipitating intensive care unit admission in patients with hematological malignancies: impact on outcome Intensive Care Med 31 2005 934 942
17. A.G. Freifeld, E.J. Bow, K.A. Sepkowitz, M.J. Boeckh, J.I. Ito, and C.A. Mullen Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America Clin Infect Dis 52 2011 e56 e93
18. E. Tacconelli, G. De Angelis, M.A. Cataldo, E. Mantengoli, T. Spanu, and A. Pan Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study Antimicrob Agents Chemother 53 2009 4264 4269
19. A.D. Harris, T.B. Karchmer, Y. Carmeli, and M.H. Samore Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review Clin Infect Dis 32 2001 1055 1061
20. A.D. Harris, M.H. Samore, and Y. Carmeli Control group selection is an important but neglected issue in studies of antibiotic resistance Ann Intern Med 133 2000 159
21. K. Shigemura, S. Arakawa, Y. Sakai, S. Kinoshita, K. Tanaka, and M. Fujisawa Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003) Int J Urol 13 2006 538 542
22. K.S. Kaye, J.J. Engemann, E. Mozaffari, and Y. Carmeli Reference group choice and antibiotic resistance outcomes Emerg Infect Dis 10 2004 1125 1128